Are you actually losing fat — or are you losing you?
Ozempic and Wegovy are the same drug — semaglutide — approved for different conditions. Ozempic is licensed for type 2 diabetes management. Wegovy is licensed for chronic weight management. Both suppress appetite through GLP-1 receptor agonism. Both produce substantial weight loss in clinical trials. And both produce lean mass loss alongside it.
For most people, that lean mass loss goes unnoticed. The scales are moving in the right direction, the clothes feel different and the energy may have improved. Why would you look more closely?
Because after 50, muscle loss matters in ways it did not at 35. Strength, physical function, bone density and the body's ability to manage weight long term all depend on lean tissue. Losing a significant amount of it — quietly, invisibly, while the total weight number falls — is worth understanding.
This page covers what the evidence shows about lean mass during semaglutide treatment, why it matters more after 50 and what to do about it. For the complete clinical picture — mechanisms, detailed protocol, nutrition guidance and peer-reviewed sources — read the full GLP-1 Muscle Loss Over 50 guide.
Substantial caloric restriction — however it is achieved — produces losses of both fat and lean tissue. Semaglutide is extremely effective at producing that caloric restriction. It does not, however, direct the body to draw exclusively from fat stores.
A 2026 systematic review and meta-analysis of 20 randomised controlled trials found that lean mass accounted for approximately 25 to 39 percent of total weight lost with incretin-based therapies. The same analysis found a more favourable lean mass profile when resistance training was part of the treatment.
A separate finding deserves attention: some studies have shown that GLP-1 users become less physically active after starting treatment — taking fewer steps and spending less time exercising. Reduced energy intake, appetite suppression and gastrointestinal side effects can all contribute. The medication may be working while the behaviour that would protect muscle from loss is declining.
Lean mass is not the same thing as skeletal muscle — and that distinction matters.
Clinical studies commonly measure lean or fat-free mass rather than skeletal muscle directly. Lean mass includes water, organs and other non-fat tissues alongside muscle. A reduction in lean mass should not automatically be described as an equivalent loss of skeletal muscle. The more productive question is not "how much muscle am I losing?" but "what am I doing to improve the quality of this weight loss?" — meaning more fat lost, less lean tissue lost, and strength and function preserved throughout.
The over-50 adult taking Ozempic or Wegovy is not starting from the same baseline as a younger user. Muscle mass, strength and physical function tend to decline with age unless the body is given a reason to maintain them. That process is already underway before any medication is introduced.
Adding substantial lean mass loss from rapid weight loss to a baseline already under pressure makes the case for muscle preservation more urgent — not less.
The goal is not simply to become lighter. It is to become healthier without unnecessarily sacrificing physical capacity.
Rising from a chair, climbing stairs, carrying groceries and recovering from a stumble all depend on muscular strength. These capabilities become more important, not less, as the years advance.
Older muscle is less responsive to the anabolic signals from food and exercise than younger muscle. Muscle lost during treatment is not easily recovered afterwards. Prevention is considerably more efficient than recovery.
Research links semaglutide use to reductions in bone mineral density. A 2024 JAMA study showed that combining GLP-1 therapy with exercise preserved density at the hip and spine. For post-menopausal women already losing bone mass, this is a compounding risk.
Muscle is metabolically active. Preserving it during weight loss helps protect the basal metabolic rate that long-term weight management depends on. Losing substantial lean mass during treatment makes weight regain more likely after it ends.
Worth knowing: GLP-1 medications are an effective tool for many people. The argument here is not against them. It is for using them alongside the training and nutrition habits that preserve what the medication cannot protect on its own.
The training does not need to be intensive or time-consuming. Research confirms that structured resistance training during GLP-1 treatment does not need to be heroic to produce a meaningful muscle-preservation effect. It needs to be consistent, progressive and present throughout the treatment period.
The muscle preservation benefit of resistance training is greatest when it is present throughout the period of rapid weight loss. Do not wait until you have reached your target weight. If you are starting Ozempic or Wegovy, establish a resistance training habit at the same time. If you are already taking the medication, start now.
Squatting, hinging, pressing, pulling and carrying movements train large amounts of muscle with a relatively small number of exercises. For someone whose energy may be reduced by appetite suppression, these movements provide the most benefit per session and are the most practical foundation for consistent training.
You do not need to train five days a week. Two sessions per week well-structured resistance training provide a practical and meaningful muscle-preservation stimulus. That is the floor, not the ceiling — but two consistent sessions are worth considerably more than five sporadic ones.
The body preserves muscle when it has reason to. Progressive overload — gradually increasing the challenge of the training — maintains that signal across weeks and months of treatment. A simple training log that records weights and repetitions makes it possible to see whether progress is happening and adjust when it is not.
When appetite falls, protein intake tends to fall with it. Current reviews discussing GLP-1 treatment commonly suggest prioritising protein within the available food intake, with many clinicians recommending at least around 1.2 grams per kilogram of body weight per day as a reasonable starting point. Spreading protein across meals and choosing protein-dense foods makes this easier when overall food volume is limited. Your individual target is best discussed with a registered dietitian or clinician.
Does Ozempic cause muscle loss?
Ozempic does not target muscle directly. However, because it produces substantial weight loss through appetite suppression and caloric restriction, lean mass can be lost alongside fat — as typically occurs with rapid weight loss from any cause. A 2026 meta-analysis found lean mass accounted for around 25 to 39 percent of weight lost with incretin-based therapies. Resistance training improves that ratio.
Does Wegovy cause muscle loss?
Wegovy contains the same active ingredient as Ozempic — semaglutide — at a higher approved dose for weight management. The same lean mass considerations apply. The more weight lost, the more important it becomes to protect lean tissue through structured resistance training and adequate protein intake.
Can I build muscle while taking Ozempic or Wegovy?
Building significant new muscle during a large caloric deficit is difficult regardless of the cause of that deficit. The more realistic and more important goal is preserving the muscle you already have. Progressive resistance training during treatment is the most evidence-justified way to do that. Some individuals may see modest strength improvements alongside weight loss, particularly if they were previously inactive.
What exercise is best on Ozempic or Wegovy?
Resistance training — using weights, resistance bands or bodyweight — is the exercise most directly supported by evidence for lean mass preservation during GLP-1 treatment. Walking and other cardiovascular activity are valuable for overall health but do not provide the same muscle-preservation stimulus. The combination of both is better than either alone.
I feel too tired to exercise on Ozempic. What should I do?
Fatigue, nausea and reduced energy are common in the early weeks of semaglutide treatment, particularly during dose increases. If symptoms are severe or persistent, speak to the clinician managing your medication. In the meantime, shorter, lower-intensity sessions may be more sustainable than trying to maintain the same training volume as before. Something is considerably better than nothing — and consistency over months matters more than intensity in any single session.
The GLP-1 Muscle Loss Over 50 guide covers the complete evidence base for lean mass changes on incretin-based therapies, the biological mechanisms involved, the detailed nutrition protocol including per-meal protein guidance, a monitoring framework and the peer-reviewed sources behind every claim on this page.
For the complete evidence, mechanisms and detailed protocol — read the GLP-1 Muscle Loss Over 50 guide. For the biology of age-related muscle loss that makes this issue most urgent after 50 — read Sarcopenia Over 50.
Ozempic and Wegovy can produce the weight loss. Resistance training determines how much of what disappears is fat — and how much is the muscle you spent years building.
This page provides educational information about resistance training and semaglutide-based weight-loss medications. It is not medical advice and does not replace the guidance of the clinician prescribing your medication. Individual exercise and nutrition requirements may be affected by diabetes, kidney disease, cardiovascular disease, gastrointestinal symptoms, other medications, previous injuries or other medical conditions. Speak to the clinician managing your medication before making significant changes to your exercise programme or diet.
The following peer-reviewed studies informed the claims on this page.
The Minimum 12
Twelve fundamental compound movements organised into a simple twice-weekly framework. Designed for the over-50 natural trainee who wants a productive, sustainable strength programme — whether or not they are taking a GLP-1 medication.
Get The Minimum 12 — £19 Instant download · PDF · 18 pages · One-time payment